Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / AUTL - Autolus stock rises as Moderna uses option to license targeting technology for mRNA therapy

AUTL - Autolus stock rises as Moderna uses option to license targeting technology for mRNA therapy

Autolus Therapeutics plc

  • Autolus Therapeutics ( NASDAQ: AUTL ) said Moderna ( NASDAQ: MRNA ) exercised an option to license AUTL's proprietary binders against an undisclosed immuno-oncology target to develop and commercialize mRNA therapeutics.
  • Autolus ( AUTL ) received an option exercise fee, with potential for development milestone payments plus royalties, the company said in an Oct. 12 press release.
  • The transaction follows an original August 2021 agreement between the two companies, granting Moderna an exclusive option to license Autolus' binders for up to four immuno-oncology targets for use in certain mRNA therapeutics.
  • AUTL +4.03% to $3.10 premarket Oct. 12

For further details see:

Autolus stock rises as Moderna uses option to license targeting technology for mRNA therapy
Stock Information
Company Name: Autolus Therapeutics plc
Stock Symbol: AUTL
Market: NASDAQ
Website: autolus.com
Menu
AUTL AUTL Quote AUTL Short AUTL News AUTL Articles AUTL Message Board
Get AUTL Alerts

News, Short Squeeze, Breakout and More Instantly...